Interdiction of Sphingolipid Metabolism to Improve Standard Cancer Therapies

Advances in Cancer Research - United States
doi 10.1016/b978-0-12-394274-6.00001-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier

Related search

Sphingolipid Metabolism and Molecular Target Drugs for Cancer

Journal of The Society of Japanese Women Scientists
2017English

Combined Therapies Improve Survival in Aggressive Prostate Cancer

Cancer
Cancer ResearchOncology
2018English

Targeted Therapies to Improve Tumor Immunotherapy

Clinical Cancer Research
Cancer ResearchOncology
2008English

Combining Information From Cancer Registry and Medical Records Data to Improve Analyses of Adjuvant Cancer Therapies

Biometrics
StatisticsGeneticsProbabilityMolecular BiologyBiochemistryApplied MathematicsMicrobiology ImmunologyBiological SciencesMedicineAgricultural
2009English

Connecting Hsp70, Sphingolipid Metabolism and Lysosomal Stability

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2010English

Isc1 Regulates Sphingolipid Metabolism in Yeast Mitochondria

Biochimica et Biophysica Acta - Biomembranes
BiochemistryCell BiologyBiophysics
2007English

Using Evidence to Improve Psychological Therapies Services

Mental Health and Learning Disabilities Research and Practice
2005English

Evidence for Disruption of Sphingolipid Metabolism in Schizophrenia

Journal of Neuroscience Research
Molecular NeuroscienceCellular
2009English

Network-Based Analysis of the Sphingolipid Metabolism in Hypertension

Frontiers in Genetics
GeneticsMolecular Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy